Starch nanoparticles for delivery of the histone deacetylase inhibitor CG-1521 in breast cancer treatment

References

• National Cancer Institute webpage on the InternetCancer Stat Facts: Female Breast Cancer Available from: https://seer.cancer.gov/statfacts/html/breast.htmlAccessed December 12, 2017
   Google Scholar
• JainKKNanotechnology-based drug delivery for cancerTechnol Cancer Res Treat20054440741616029059
   PubMed Web of Science ®Google Scholar
• UrbinatiGMarsaudVPlassatVFattalELesieurSRenoirJMLiposomes loaded with histone deacetylase inhibitors for breast cancer therapyInt J Pharm20103971–218419320603204
   PubMedGoogle Scholar
• FanTLiMWuXLiMWuYPreparation of thermoresponsive and pH-sensitivity polymer magnetic hydrogel nanospheres as anticancer drug carriersColloids Surf B Biointerfaces201188259360021871786
   PubMedGoogle Scholar
• WangFLiLLiuBChenZLiCHyaluronic acid decorated Pluronic p85 solid lipid nanoparticles as a potential carrier to overcome multi-drug resistance in cervical and breast cancerBiomed Pharmacother20178659560428027535
   PubMed Web of Science ®Google Scholar
• LinGZhangHHuangLSmart polymeric nanoparticles for cancer gene deliveryMol Pharm201512231432125531409
   PubMed Web of Science ®Google Scholar
• PatelTZhouJPiepmeierJMSaltzmanWMPolymeric nanoparticles for drug delivery to the central nervous systemAdv Drug Deliv Rev201264770170522210134
   PubMed Web of Science ®Google Scholar
• BenekeCEViljoenAMHammanJHPolymeric plant-derived excipients in drug deliveryMolecules20091472602262019633627
   PubMed Web of Science ®Google Scholar
• KataokaKHaradaANagasakiYBlock copolymer micelles for drug delivery: design, characterization and biological significanceAdv Drug Deliv Rev200147111313111251249
   PubMed Web of Science ®Google Scholar
• MengLHuangWWangDHuangXZhuXYanDChitosan-based nanocarriers with pH and light dual response for anticancer drug deliveryBiomacromolecules20131482601261023819825
   PubMed Web of Science ®Google Scholar
• FarokhzadOCLangerRNanomedicine: developing smarter therapeutic and diagnostic modalitiesAdv Drug Deliv Rev200658141456145917070960
   PubMed Web of Science ®Google Scholar
• GryparisECHatziapostolouMPapadimitriouEAvgoustakisKAnticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cellsEur J Pharm Biopharm20076711817303395
   PubMed Web of Science ®Google Scholar
• MobasseriRKarimiMTianLNaderi-ManeshHRamakrishnaSHydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property and in vitro anti-cancer activityMat Sci Eng C201774413421
   PubMed Web of Science ®Google Scholar
• ÖsterbergEBergströmKHolmbergKProtein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEGJ Biomed Mater Res19952967417477593011
   PubMed Web of Science ®Google Scholar
• SarikaeoKStarch: introduction and structure-property relationshipVisakhPMLongYStarch-Based Blends, Composites and NanocompositesLondonThe Royal Society of Chemistry20161748
   Google Scholar
• MarquesAPReisRLHuntJAThe biocompatibility of novel starch-based polymers and composites: in vitro studiesBiomaterials20022361471147811829443
   PubMed Web of Science ®Google Scholar
• WuXChangYFuYRenLTongJZhouJEffects of non-solvent and starch solution on formation of starch nanoparticles by nanoprecipitationStarch Stärke2016683–4258263
   Google Scholar
• Mahmoudi NajafiSHBaghaieMAshoriAPreparation and characterization of acetylated starch nanoparticles as drug carrier: ciprofloxacin as a modelInt J Biol Macromol201687485426893054
   PubMed Web of Science ®Google Scholar
• PangSCChinSFNadirahATaySHYazidSNAMFabrication of polysaccharide-based nanoparticles as drug delivery nanocarriersECS Transactions201566371532
   Google Scholar
• El-NaggarMEEl-RafieMHEl-SheikhMAEl-FekyGSHebeishASynthesis, characterization, release kinetics and toxicity profile of drug-loaded starch nanoparticlesInt J Biol Macromol20158171872926358550
   PubMed Web of Science ®Google Scholar
• PandolfiPPTranscription therapy for cancerOncogene200120243116312711420728
   PubMedGoogle Scholar
• RichonVMEmilianiSVerdinEA class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylasesProc Natl Acad Sci1998956300330079501205
   PubMed Web of Science ®Google Scholar
• LaneAAChabnerBAHistone deacetylase inhibitors in cancer therapyJ Clin Oncol200927325459546819826124
   PubMed Web of Science ®Google Scholar
• de RuijterAJMKempSKramerGThe novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cellsBiochem Pharmacol20046871279128815345317
   PubMed Web of Science ®Google Scholar
• RoySPackmanKJeffreyRTenniswoodMHistone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cellsCell Death Differ200512548249115746940
   PubMed Web of Science ®Google Scholar
• ChatterjeeNWangWLConklinTChitturSTenniswoodMHistone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cellsCancer Biol Ther201314765867123792638
   PubMed Web of Science ®Google Scholar
• ElautGTörökGVinkenMMajor phase I biotransformation pathways of trichostatin A in rat hepatocytes and in rat and human liver microsomesDrug Metab Dispos200230121320132812433798
   PubMed Web of Science ®Google Scholar
• VanhaeckeTPapeleuPElautGRogiersVTrichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of viewCurr Med Chem200411121629164315180568
   PubMedGoogle Scholar
• NiwaTTakeuchiHHinoTKunouNKawashimaYIn vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion methodJ Pharm Sci19948357277328071830
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• BlancoEShenHFerrariMPrinciples of nanoparticle design for overcoming biological barriers to drug deliveryNat Biotechnol201533994195126348965
   PubMed Web of Science ®Google Scholar
• KnutsonAKWelshJTaylorTRoySWangWLTenniswoodMComparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cellsOncol Rep201227384985322159450
   PubMedGoogle Scholar
• ChatterjeeNTenniswoodMThe potential of histone deacetylase inhibitors in breast cancer therapyBreast Cancer Manag2015428597
   Google Scholar
• DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev199951469174310581328
   PubMed Web of Science ®Google Scholar
• MaedaHFangJInutsukaTKitamotoYVascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implicationsInt Immunopharmacol20033331932812639809
   PubMed Web of Science ®Google Scholar
• MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
   PubMed Web of Science ®Google Scholar
• TranTHChoiJYRamasamyTHyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cellsCarbohydr Polym201411440741525263908
   PubMed Web of Science ®Google Scholar
• El BahhajFDenisIPichavantLHistone deacetylase inhibitors delivery using nanoparticles with intrinsic passive tumor targeting properties for tumor therapyTheranostics20166679580727162550
   PubMed Web of Science ®Google Scholar
• WangECMinYPalmRCNanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumorsBiomaterials20155120821525771011
   PubMed Web of Science ®Google Scholar
• SunYZouWBianSBioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinomaBiomaterials201334286818682823764117
   PubMedGoogle Scholar
• SafwatSHathoutRMIshakRAMortadaNDAugmented simvastatin cytotoxicity using optimized lipid nanocapsules: a potential for breast cancer treatmentJ Liposome Res201727111026872624
   PubMed Web of Science ®Google Scholar
• AbozeidSMHathoutRMAbou-AishaKSilencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7145Colloids Surf B Biointerfaces201660761627285732
   PubMedGoogle Scholar